by Eclosion Team | Mar 28, 2017 | Uncategorized
Geneva (Switzerland), March 28, 2017 : GeNeuro (Euronext Paris : CH0308403085 – GNRO), a biopharmaceutical company developing new treatments for neurological disorders and autoimmune diseases, including multiple sclerosis (MS), today provided access to research on...
by Eclosion Team | Mar 21, 2017 | Uncategorized
Lyon, France – 21 March 2017 – NETRIS Pharma Starts Enrollment of First Clinical Study to Evaluate Drug Candidate Targeting Dependence Receptors. NETRIS Pharma, a pioneer in the development of dependence receptor targeted cancer medicines, announced today the start of...